What is Automation and Control System in Healthcare- Market?
Healthcare automation and digitalization have made the processing of health insurance claims easier and error-free. Automation is all about reimagining the healthcare system by enabling various efficiencies that would be impossible to work on manually. Automation providers and medical device manufacturers can reduce the costs substantially, achieve greater flexibility, and improve functionality by shifting to a cloud-based environment.
Highlights from Automation and Control System in Healthcare- Market Study
Attributes | Details |
---|
Study Period | 2017-2027 |
Base Year | 2021 |
Unit | Value (USD Million) |
Key Companies Profiled | Jabil (United States), Invotec, Inc. (United States), Koninklijke Philips (Netherlands), Danaher Corporation (United States), Medtronic (Ireland), Stryker Corporation (United States), General Electric Company (United States), Siemens (Germany), Tecan Group (Switzerland), Swisslog Holding (Switzerland), Intuitive Surgical (United States) and Honeywell International (United States) |
The key manufacturers are targeting the innovations of the products with better quality, and also assist in providing and humanizing the after-sale service to the consumers. The key players are probable to keep a stronghold on the market over the anticipated period. The key players are accepting strategic decisions and are thinking upon mergers and acquisitions in order to maintain their presence in the market Research Analyst at AMA predicts that United States Players will contribute to the maximum growth of Global Automation and Control System in Healthcare- market throughout the forecasted period.
Jabil (United States), Invotec, Inc. (United States), Koninklijke Philips (Netherlands), Danaher Corporation (United States), Medtronic (Ireland), Stryker Corporation (United States), General Electric Company (United States), Siemens (Germany), Tecan Group (Switzerland), Swisslog Holding (Switzerland), Intuitive Surgical (United States) and Honeywell International (United States) are some of the key players profiled in the study. Automation and Control System in Healthcare- Market Segmentation:
Scope | Sub-Segments |
---|
Application / End User | Hospitals & Diagnostic Centers, Research Laboratories & Institutes, Pharmacies and Others |
Type | Diagnostics and Monitoring Automation, Therapeutic Automation, Pharmacy and Laboratory Automation and Medical Logistics & Training Automation |
Components | Sensors,Controllers,Output Devices,Others |
On the basis of geography, the market of Automation and Control System in Healthcare- has been segmented into
. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
Influencing Trend:
Healthcare sector for monitoring real-time data along with the provision of real-time doctor and equipment location and Increasing Trend of Robotic Process Automation in Healthcare work
Market Growth Drivers:
Increase use of Automation in Healthcare Due to Smart Digital Processes and Rapidly Improve the Efficiency of their Medical Unit and The growing demand for process automation and data centralization is currently propelling the global healthcare automation industry towards growth.
Challenges:
Challenges Regarding Creativity and Innovation in the Automation and Control System in Healthcare Industry
Restraints:
The Adoption of Automation in Healthcare Industries has been Slower
Opportunities:
Increasing Automation Aids are Consistently Emerging and Growing Government Investment and Initiatives in the Healthcare Sectors
Key Target Audience
Automation and Control System in Healthcare Manufacturers, Suppliers and Distributors of Automation and Control System in Healthcare, Regulatory Bodies, Potential Investors, Research and Development Institutes and Others
Market Leaders & Development Strategies
On 6th June 2022, Hungry for a slice of the budding pharmacy automation market, medical technology firm Becton, Dickinson and Company announced today plans to acquire Parata Systems for more than USD 1.5 billion. “Parata has a highly attractive financial profile and compelling value proposition that meets all of our rigorous investment criteria on growth, profitability and returns,” Tom Polen, chairman, CEO and president of BD, said in a statement.